Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,201 | 209,918 | 123,925 | 40,042 | 46,803 |
| TOTAL | $162,528 | $212,269 | $127,220 | $40,520 | $47,244 |
| Non-Current Assets | |||||
| PPE Net | 823 | 957 | 1,107 | 1,056 | 521 |
| Other Non-Current Assets | 4,619 | 1,613 | 257 | 812 | 697 |
| TOTAL | $5,442 | $2,570 | $1,364 | $1,868 | $1,218 |
| Total Assets | $167,970 | $214,839 | $128,583 | $42,388 | $48,462 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,436 | 2,664 | 2,647 | 1,565 | 564 |
| Accrued Expenses | 8,711 | 6,001 | 3,567 | 3,267 | 6,146 |
| Other current liabilities | N/A | N/A | 1,883 | 1,433 | 1,037 |
| TOTAL | $10,951 | $8,763 | $8,175 | $6,334 | $7,747 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 99 | 78 | 69 | N/A |
| Other Non-Current Liabilities | 2,819 | 0 | 0 | 0 | 0 |
| TOTAL | $2,819 | $612 | $707 | $754 | $244 |
| Total Liabilities | $13,769 | $9,375 | $8,882 | $7,087 | $7,991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 436 | 432 | 344 | 233 | 191 |
| Common Shares | 44 | 43 | 34 | 23 | 19 |
| Retained earnings | -258,443 | -200,551 | -152,277 | -118,976 | -87,167 |
| TOTAL | $154,201 | $205,465 | $119,701 | $35,301 | $40,472 |
| Total Liabilities And Equity | $167,970 | $214,839 | $128,583 | $42,388 | $48,462 |